Purchase Order 75N94020P00419

Award Date 6/8/20
Potential Completion Date 6/8/21
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Shawnee, KS 66220, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $20,000.00 firm fixed price purchase order contract to Leadingedge Pharmtox, LLC, a self-certified small disadvantaged business, for toxicology consulting services related to reproductive science and health. The contract, which was set aside for small businesses, has an ultimate completion date of August 24, 2025. Leadingedge Pharmtox, LLC...
This firm fixed-price purchase order contract was awarded by the National Institute of Child Health and Human Development (NICHD), a division of the U.S. Department of Health and Human Services, to Leadingedge Pharmtox, LLC, a self-certified small disadvantaged business located in Kearney, Missouri. The $12,500.00 contract is for toxicology consulting services to support NICHD's reproductive science research initiatives, with a period of performance through August 24, 2026. Leadingedge Pharmtox,...
Leadingedge Pharmtox, LLC has been awarded a $20,000 purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development to provide toxicology consulting services for reproductive science. The firm fixed price contract runs from August 2023 through August 2024 and will be performed in Kearney, Missouri. It has been set aside for total small businesses. The National Institute of Child Health and Human Development...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, awarded a $25,000.00 firm-fixed-price purchase order to Gardner Pharmacology LLC, a woman-owned small business, for pharmacology consulting services. The contract does not have a set-aside designation. The services provided under this award include pre-clinical and clinical pharmacology consulting, expert consultation on ethical, policy, and regulatory...
The National Institute of Child Health and Human Development (NICHD), a civilian federal agency, awarded a $4,000.00 firm fixed-price purchase order contract to Linda L. Chezem, a self-certified small disadvantaged business, economically disadvantaged women-owned small business, and woman-owned business. The contract has an ultimate completion date of September 30, 2011 and was awarded on June 1, 2011. This contract was not set aside for any specific business type. The contract's purpose and...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services (HHS). The $11,578 firm fixed-price purchase order was awarded to Global Life Sciences Solutions USA LLC, a for-profit limited liability company that provides technologies and services for the development and manufacture of therapeutics. The contract does not have a set-aside designation. The contract award indicates...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to BDX Research & Consulting LLC, a minority-owned, small disadvantaged business. The $76,000 contract is for research support services for Dr. Joseph, with a performance period ending on July 31, 2023. The contract does not have a set-aside designation. BDX Research & Consulting LLC is a...
This purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health to Linda L. Chezem as the prime contractor. The contract valued at $10,612.22 is being funded by NIH's National Institute of Child Health and Human Development to support research activities at its Bethesda, Maryland campus. The firm fixed price contract has a period of performance from October 24, 2011 through November 24, 2011. No major subcontractors or set aside designations...
This federal contract award was made by the National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services, to Tecniplast USA, Inc., a for-profit manufacturer of specialized laboratory equipment and supplies, primarily focused on supporting biomedical research programs. The $5,986.44 firm-fixed-price purchase order did not have a set-aside designation. Tecniplast is the prime contractor and no subcontractors are mentioned. The award...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, awarded a $24,872.40 firm fixed-price purchase order to Gardner Pharmacology LLC, a woman-owned small business, for pharmacology consulting services related to the institute's contraception research programs. The services include providing expert consultation on pre-clinical and clinical pharmacology, ethical and regulatory issues, and other specialized...

This federal contract award, valued at $25,000.00, was made by the National Institute of Child Health and Human Development (NICHD) to Leadingedge Pharmtox, LLC, a small disadvantaged business, to provide toxicology consulting services related to reproductive science and health. The contract, which was not set aside, involves reviewing, monitoring, and reporting on the safety of NICHD-funded research projects focused on reproduction, development, and potential health impacts. Leadingedge Pharmtox, LLC has previously received similar prime contracts from NICHD to assess the reproductive and developmental effects of various research initiatives. This contract is structured as a firm fixed-price purchase order with a period of performance ending on June 8, 2021.

Generated 3/15/25, 9:51 AM